EGFR and breast neoplasm: For example, to selectively target breast tumors overexpressing Epidermal Growth Factor Receptors (EGFR), we also developed the actively-targeted FNP by conjugating fluorescent poly lactic-co-glycolic acid (PLGA) nanospheres with anti-EGFR antibodies (9).